Cargando…
An Open‐label Phase 1 Dose‐escalation Clinical Trial of a Single Intravenous Administration of Gemcitabine in Dogs with Advanced Solid Tumors
BACKGROUND: A broad range of gemcitabine dosages have been used in dogs. HYPOTHESIS/OBJECTIVES: To determine maximally tolerated dose (MTD), dose‐limiting toxicity (DLT), and preliminary antitumor activity of intravenous administration of gemcitabine in dogs with advanced solid tumors. ANIMALS: Twen...
Autores principales: | Marconato, L., Finotello, R., Bonfanti, U., Dacasto, M., Beatrice, L., Pizzoni, S., Leone, V.F., Balestra, G., Furlanello, T., Rohrer Bley, C., Aresu, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895507/ https://www.ncbi.nlm.nih.gov/pubmed/25818216 http://dx.doi.org/10.1111/jvim.12557 |
Ejemplares similares
-
Concordance of c‐kit Mutational Status in Matched Primary and Metastatic Cutaneous Canine Mast Cell Tumors at Baseline
por: Marconato, L., et al.
Publicado: (2013) -
Efficacy of Intravenous Administration of Combined Acid Suppressants in Healthy Dogs
por: Tolbert, M.K., et al.
Publicado: (2015) -
Early Tumor Response to Intraarterial or Intravenous Administration of Carboplatin to Treat Naturally Occurring Lower Urinary Tract Carcinoma in Dogs
por: Culp, W.T.N., et al.
Publicado: (2015) -
Hypomagnesemia in Brachycephalic Dogs
por: Mellema, M.S., et al.
Publicado: (2014) -
Effect of Synthetic Colloid Administration on Coagulation in Healthy Dogs and Dogs with Systemic Inflammation
por: Gauthier, V., et al.
Publicado: (2015)